{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:32:50Z","timestamp":1783567970262,"version":"3.55.0"},"reference-count":108,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Cholesteatoma is a prevalent disease affecting both children and adults. In this review, we present the recent findings related to the molecular mechanisms involved in cholesteatoma and discuss how researchers can target new molecules to treat this disease. These new approaches illustrate the paradigm shift from a primarily surgical solution to a biological \u201ccontrol and prevent\u201d strategy.<\/jats:p>","DOI":"10.3390\/ijms26199545","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:38:55Z","timestamp":1759246735000},"page":"9545","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Emerging Paradigms in Cholesteatoma: From a Traditional Approach to Personalized Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-9126","authenticated-orcid":false,"given":"Adina","family":"Zamfir-Chiru-Anton","sequence":"first","affiliation":[{"name":"\u201cGrigore Alexandrescu\u201d Emergency Hospital for Children, 011743 Bucharest, Romania"},{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Manda","sequence":"additional","affiliation":[{"name":"\u201cC.I. Parhon\u201d National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Cristian","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u201cMarie Curie\u201d Emergency Hospital for Children, 077120 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"ref_1","unstructured":"Kennedy, K.L., and Singh, A.K. (2025). Middle Ear Cholesteatoma, StatPearls."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111289","DOI":"10.1016\/j.ijporl.2022.111289","article-title":"Middle ear cholesteatoma prevalence in over 3600 children with Turner Syndrome","volume":"161","author":"Dorney","year":"2022","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.12998\/wjcc.v10.i28.10220","article-title":"Potential otogenic complications caused by cholesteatoma of the contralateral ear in patients with otogenic abscess secondary to middle ear cholesteatoma of one ear: A case report","volume":"10","author":"Zhang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.anorl.2011.09.005","article-title":"Imaging of non-operated cholesteatoma: Clinical practice guidelines","volume":"129","author":"Ayache","year":"2012","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5114\/pjr\/203991","article-title":"Detection of cholesteatoma recurrence by magnetic resonance imaging (DWI non-EPI sequence)\u2014How can we minimise false results?","volume":"90","author":"Pietraszek","year":"2025","journal-title":"Pol. J. Radiol."},{"key":"ref_6","unstructured":"Muller, J. (1838). \u00dcber den Feineren Bau und die Formen der Krankhaften Geschw\u00fclste, Reimer."},{"key":"ref_7","first-page":"294","article-title":"Tympanic Epidermosis: A Noncholesteatomatous Keratinizing Entity of Chronic Otitis Media","volume":"5","author":"Huy","year":"2009","journal-title":"J. Int. Adv. Otol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/MAO.0000000000003246","article-title":"Treatment Outcome of the Bony Obliteration Tympanoplasty Versus Nonobliterative Techniques in Cholesteatoma Surgery: A Retrospective Analysis","volume":"42","author":"Metselaar","year":"2021","journal-title":"Otol. Neurotol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/audiolres13010008","article-title":"Facial Palsy Secondary to Cholesteatoma: A Case-Series of 14 Patients","volume":"13","author":"Psillas","year":"2023","journal-title":"Audiol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110887","DOI":"10.1016\/j.ijporl.2021.110887","article-title":"Long term outcomes of canal wall up and canal wall down tympanomastoidectomies in pediatric cholesteatoma","volume":"150","author":"Piras","year":"2021","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.anorl.2011.01.009","article-title":"Residual cholesteatoma: Prevalence and location. Follow-up strategy in adults","volume":"129","author":"Gaillardin","year":"2012","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/lary.25591","article-title":"The disease recurrence rate after the canal wall up or canal wall down technique in adults","volume":"126","author":"Kerckhoffs","year":"2016","journal-title":"Laryngoscope"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/lary.30413","article-title":"Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta-analysis","volume":"133","author":"Illes","year":"2023","journal-title":"Laryngoscope"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"James, A.L. (2024). Cholesteatoma Severity Determines the Risk of Recurrent Paediatric Cholesteatoma More Than the Surgical Approach. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030836"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1055\/s-0039-1697989","article-title":"Recurrence of Cholesteatoma\u2014A Retrospective Study Including 1,006 Patients for More than 33 Years","volume":"24","author":"Pedersen","year":"2020","journal-title":"Int. Arch. Otorhinolaryngol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1017\/S0022215100141581","article-title":"Surgery for acquired cholesteatoma in children: Long-term results and recurrence of cholesteatoma","volume":"112","author":"Stangerup","year":"1998","journal-title":"J. Laryngol. Otol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/lary.23510","article-title":"How long is long enough to follow up children after cholesteatoma surgery? A 29-year study","volume":"122","author":"Kuo","year":"2012","journal-title":"Laryngoscope"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/iao.2017.3363","article-title":"EAONO\/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma","volume":"13","author":"Yung","year":"2017","journal-title":"J. Int. Adv. Otol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ijporl.2006.03.008","article-title":"Iatrogenic cholesteatoma in children with OME in a training program","volume":"70","year":"2006","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archotol.125.7.754","article-title":"Cholesteatomas associated with ventilation tube insertion","volume":"125","author":"Golz","year":"1999","journal-title":"Arch. Otolaryngol. Neck Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00405-023-08251-y","article-title":"Acquired cholesteatoma after cochlear implants: Case series and literature review","volume":"281","author":"Sykopetrites","year":"2024","journal-title":"Eur. Arch. Oto Rhino Laryngol."},{"key":"ref_22","unstructured":"St. John Roosa, D.B. (1864). The Diseases of the Ear, Their Diagnosis and Treatment: A Text-Book of Aural Surgery in the Form of Academic Lectures, William Wood. Translated from the German."},{"key":"ref_23","first-page":"428","article-title":"Desquamative Entz\u00fcndung des Mittelohres (\u201cCholesteatom des Felsenbeins\u201d)","volume":"14","author":"Wendt","year":"1873","journal-title":"Arch Ohr Nasen Kehlkopfheilk"},{"key":"ref_24","unstructured":"Lange, H.O. (1925). Das Weisheitsbuch Amenemope: Aus Papyrus 10,474 BRITISH Museum, AF H\u00f8st & s\u00f8n."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01583540","article-title":"Wie entsteht ein genuines Cholesteatom?","volume":"137","author":"Wittmaack","year":"1933","journal-title":"Arch. Ohren Nasen Kehlkopfheilkd"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000275513","article-title":"Cholesteatoma: Etiology Nosology and Tympanoplasty","volume":"42","author":"Wullstein","year":"1980","journal-title":"ORL"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lary.25261","article-title":"A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction","volume":"125","author":"Jackler","year":"2015","journal-title":"Laryngoscope"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2273.1991.tb01970.x","article-title":"The nature of the epithelium in acquired cholesteatoma","volume":"16","author":"Lee","year":"1991","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"ref_29","first-page":"1","article-title":"Pathogenesis and surgical treatment of the middle ear cholesteatoma","volume":"361","author":"Ruedi","year":"1979","journal-title":"Acta Oto Laryngol. Suppl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1288\/00005537-198908000-00002","article-title":"Post-traumatic cholesteatoma","volume":"99","author":"McKennan","year":"1989","journal-title":"Laryngoscope"},{"key":"ref_31","first-page":"7","article-title":"Molecular biology of cholesteatoma","volume":"55","author":"Maniu","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0109298673404489250515074316","article-title":"Cholesteatoma: An Updated Review of Molecular Pathogenesis and Potential Therapeutic Directions","volume":"32","author":"Xing","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dambergs, K., Sumeraga, G., and Pilmane, M. (2023). Morphopathogenesis of Adult Acquired Cholesteatoma. Medicina, 59.","DOI":"10.3390\/medicina59020306"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijporl.2016.01.008","article-title":"Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients","volume":"82","author":"Erdag","year":"2016","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.26650\/Tr-ENT.2025.1575560","article-title":"Pyroptosis and Oxidative Stress in Chronic Otitis Media","volume":"35","author":"Ayral","year":"2025","journal-title":"Turk. J. Ear Nose Throat"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-023-40094-3","article-title":"Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destruction","volume":"14","author":"Shimizu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00405-025-09322-y","article-title":"Cholesteatoma aggressiveness in paediatric vs. adult patients: A comparative analysis of molecular markers with MERI and EAONO\/JS staging","volume":"282","author":"Karthikeyan","year":"2025","journal-title":"Eur. Arch. Oto Rhino Laryngol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0196-0709(95)90060-8","article-title":"Involvement of interleukin-1 in middle ear cholesteatoma","volume":"16","author":"Shiwa","year":"1995","journal-title":"Am. J. Otolaryngol."},{"key":"ref_39","first-page":"350","article-title":"Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear","volume":"13","author":"Schilling","year":"1992","journal-title":"Am. J. Otolaryngol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3892\/etm.2021.10660","article-title":"IL-1\u03b1, IL-6 and IL-8 serum values in patients with chronic suppurative otitis media","volume":"22","author":"Serban","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dambergs, K., Sumeraga, G., and Pilmane, M. (2024). Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma. Diagnostics, 14.","DOI":"10.3390\/diagnostics14060662"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/00016489850183485","article-title":"Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium","volume":"118","author":"Chung","year":"1998","journal-title":"Acta Oto Laryngol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0194-59989570268-7","article-title":"Localization of cytokines in cholesteatoma tissue","volume":"112","author":"Marenda","year":"1995","journal-title":"Otolaryngol. Neck Surg."},{"key":"ref_44","first-page":"709","article-title":"Activation of the IL-6\/JAK\/STAT3 signaling pathway in human middle ear cholesteatoma epithelium","volume":"7","author":"Liu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_45","first-page":"813","article-title":"The role of cytokines in aquired middle ear cholesteatoma: Literature review","volume":"70","author":"Ribeiro","year":"2004","journal-title":"Rev. Bras. Otorrinolaringol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000319897","article-title":"Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma","volume":"72","author":"Haruyama","year":"2010","journal-title":"ORL J. Otorhinolaryngol Relat. Spec. Int. J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sch\u00fcrmann, M., Greiner, J.F.W., Volland-Thurn, V., Oppel, F., Kaltschmidt, C., Sudhoff, H., and Kaltschmidt, B. (2020). Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS. Cells, 9.","DOI":"10.3390\/cells9010199"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rolesi, R., Paciello, F., Paludetti, G., De Corso, E., Sergi, B., and Fetoni, A.R. (2023). Study of Angiogenic, Pro-Apoptotic, and Pro-Inflammatory Factors in Congenital and Acquired Cholesteatomas. J. Pers. Med., 13.","DOI":"10.3390\/jpm13081189"},{"key":"ref_49","first-page":"628","article-title":"Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma","volume":"37","author":"Kurzepa","year":"2008","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1808-8694(15)31122-8","article-title":"Matrix metalloproteinase 2: An important genetic marker for cholesteatomas","volume":"73","author":"Guilherme","year":"2007","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kan, T., Ueda, H., Takahara, T., Tsuchiya, Y., Kishimoto, M., Uchida, Y., Ogawa, T., Ohashi, W., Tsuzuki, T., and Fujimoto, Y. (2021). Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/6644897"},{"key":"ref_52","first-page":"4441","article-title":"Effect of CT manifestations of cholesteatoma on MMP-2, MMP-9 and IL-6 in the serum of patients","volume":"17","author":"Wu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e35538","DOI":"10.1097\/MD.0000000000035538","article-title":"Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study","volume":"102","author":"Lei","year":"2023","journal-title":"Medicine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/00016480600781807","article-title":"The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: A comparative analysis","volume":"127","author":"Mehta","year":"2007","journal-title":"Acta Oto Laryngol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbrc.2014.05.086","article-title":"Matrix metalloproteinase-14 is a mechanically regulated activator of secreted MMPs and invasion","volume":"450","author":"Haage","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10162-019-00727-1","article-title":"Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling","volume":"20","author":"Imai","year":"2019","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/00016489.2020.1717609","article-title":"Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium","volume":"140","author":"Xie","year":"2020","journal-title":"Acta Oto Laryngol."},{"key":"ref_58","first-page":"655","article-title":"PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL","volume":"49","author":"Xie","year":"2024","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wen, L., Zeng, X., Lin, Z., Chen, P., Zhao, D., and Zeng, X. (2025). TFAP2B governs the regulation of SIRT1 to inhibit osteoclast-induced bone destruction. Biochem. Biophys. Res. Commun., 752.","DOI":"10.1016\/j.bbrc.2025.151410"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2020.02.058","article-title":"Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma","volume":"525","author":"Gong","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1177\/147323001103900607","article-title":"Post-transcriptional regulation by microrna-21 and let-7a microRNA in paediatric cholesteatoma","volume":"39","author":"Chen","year":"2011","journal-title":"J. Int. Med Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/MAO.0b013e3181b4e91f","article-title":"Cholesteatoma growth and proliferation: Posttranscriptional regulation by microRNA-21","volume":"30","author":"Friedland","year":"2009","journal-title":"Otol. Neurotol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10529-014-1545-y","article-title":"Inflammation-induced miR-802 promotes cell proliferation in cholesteatoma","volume":"36","author":"Li","year":"2014","journal-title":"Biotechnol. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molimm.2021.11.017","article-title":"MiR-142-5p directly targets cyclin-dependent kinase 5-mediated upregulation of the inflammatory process in acquired middle ear cholesteatoma","volume":"141","author":"Sui","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7150\/ijms.22410","article-title":"Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma","volume":"15","author":"Zang","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3892\/mmr.2014.2971","article-title":"MicroRNA let-7a suppresses the growth and invasion of cholesteatoma keratinocytes","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5152\/iao.2023.22863","article-title":"Expression and Correlation Research of MicroRNA10a-5p and PIK3CA in Middle Ear Cholesteatoma","volume":"19","author":"Yang","year":"2023","journal-title":"J. Int. Adv. Otol."},{"key":"ref_68","first-page":"1596","article-title":"Low expression of microRNA-125b enhances the expression of STAT3 and contributes to cholesteatoma growth","volume":"18","author":"Zang","year":"2022","journal-title":"Arch. Med Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1080\/21655979.2021.1984718","article-title":"The Effect of Zbxz23ir-21 NANO(nanomaterials) Delivery Vector on Apoptosis and PTEN(phosphatase and tensin homolog deleted on chromosome ten)\/PI3K(Intracellular phosphatidylinositol kinase)\/AKT(related to the A and C kinase) in Children with CHOLESTEATOMA in Middle Ear","volume":"12","author":"Zheng","year":"2021","journal-title":"Bioengineered"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Xie, M., Tang, Q., Wang, S., Huang, X., Wu, Z., Han, Z., Li, C., Wang, B., Shang, Y., and Yang, H. (2024). Identification of miRNA expression profile in middle ear cholesteatoma using small RNA-sequencing. BMC Med. Genom., 17.","DOI":"10.1186\/s12920-024-01932-5"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00405-012-2070-z","article-title":"Oxidative stress in chronic otitis media","volume":"270","author":"Baysal","year":"2013","journal-title":"Eur. Arch. Oto Rhino Laryngol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00232-013-9561-8","article-title":"Serum myeloperoxidase activity, total antioxidant capacity and nitric oxide levels in patients with chronic otitis media","volume":"246","author":"Garca","year":"2013","journal-title":"J. Membr. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3342\/ceo.2015.8.2.97","article-title":"The evaluation of oxidative stress in the serum and tissue specimens of patients with chronic otitis media","volume":"8","author":"Garca","year":"2015","journal-title":"Clin. Exp. Otorhinolaryngol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2147\/JMDH.S414115","article-title":"The Role of Vitamins A and E Level in Chronic Suppurative Otitis Media with and without Cholesteatoma","volume":"16","author":"Boesoirie","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/00005537-200307000-00018","article-title":"Expression of hypoxia inducible factor 1 alpha and Von Hippel Lindau protein in human middle ear cholesteatoma","volume":"113","author":"Adunka","year":"2003","journal-title":"Laryngoscope"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e1233","DOI":"10.1002\/lio2.1233","article-title":"Hypoxia-inducible factor-1alpha contributes to the proliferation of cholesteatoma keratinocytes through regulating endothelin converting enzyme 1 expression","volume":"9","author":"Chen","year":"2024","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/ars.2023.0442","article-title":"Targeting Peroxisome Proliferator-Activated Receptor-beta\/delta, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy","volume":"41","author":"Kaur","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lee, D.Y., Song, M.Y., and Kim, E.H. (2021). Role of Oxidative Stress and Nrf2\/KEAP1 Signaling in Colorectal Cancer: Mechanisms and Therapeutic Perspectives with Phytochemicals. Antioxidants, 10.","DOI":"10.3390\/antiox10050743"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41514-020-00053-4","article-title":"Activation of the NRF2 pathway in Keap1-knockdown mice attenuates progression of age-related hearing loss","volume":"6","author":"Oishi","year":"2020","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10162-018-0662-z","article-title":"Keratinocyte Growth Factor (KGF) Modulates Epidermal Progenitor Cell Kinetics through Activation of p63 in Middle Ear Cholesteatoma","volume":"19","author":"Akiyama","year":"2018","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.LAB.0000050763.64145.CB","article-title":"Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma","volume":"83","author":"Aoki","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_82","first-page":"1333","article-title":"Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma","volume":"58","author":"Harabagiu","year":"2017","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"110545","DOI":"10.1016\/j.ijporl.2020.110545","article-title":"Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo","volume":"140","author":"Akiyama","year":"2021","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10162-021-00801-7","article-title":"Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma","volume":"22","author":"Akiyama","year":"2021","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cllc.2011.11.005","article-title":"Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection","volume":"13","author":"Jiang","year":"2012","journal-title":"Clin. Lung Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1245\/s10434-010-1274-y","article-title":"FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma","volume":"18","author":"Nishida","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jvs.2011.01.044","article-title":"Foxc2 overexpression enhances benefit of endothelial progenitor cells for inhibiting neointimal formation by promoting CXCR4-dependent homing","volume":"53","author":"Li","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Jiang, H., Si, Y., Li, Z., Huang, X., Chen, S., Zheng, Y., Xu, G., Chen, X., Chen, Y., and Liu, Y. (2016). TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation. Sci. Rep., 6.","DOI":"10.1038\/srep38761"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.yexmp.2009.12.006","article-title":"Immune cell profile in invasive cholesteatomas: Preliminary findings","volume":"88","author":"Hussein","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"\u00d6zdemir, \u00c7., Kuzu, S., \u015eenol, Y., Yi\u011fit, T., G\u00fcld\u00fcn, E., Bucak, A., Ulu, \u015e., and Tokyol, \u00c7. (2023). A Role for Mast Cell-Mediated Antibodies in the Formation of Cholesteatoma and Cholesteatoma-Induced Bone Erosion. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030455"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"112357","DOI":"10.1016\/j.ijporl.2025.112357","article-title":"Effect of Tacrolimus on Development of Experimental Cholesteatoma","volume":"193","author":"Kaptan","year":"2025","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archotol.124.3.261","article-title":"Cell proliferation and apoptosis in human middle ear cholesteatoma","volume":"124","author":"Kojima","year":"1998","journal-title":"Arch. Otolaryngol. Neck Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.7150\/ijms.60907","article-title":"MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN\/PI3K\/AKT pathway","volume":"18","author":"Liu","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAO.0b013e31827c9d8d","article-title":"The role of p21 and p53 proteins in congenital cholesteatoma","volume":"34","author":"Olszewska","year":"2013","journal-title":"Otol. Neurotol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Romerio, A., and Peri, F. (2020). Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01210"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kunachowicz, D., Krol-Kulikowska, M., Raczycka, W., Sleziak, J., Blazejewska, M., and Kulbacka, J. (2024). Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives. Cancers, 16.","DOI":"10.3390\/cancers16081500"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.18632\/oncotarget.22342","article-title":"Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)","volume":"9","author":"Dhanasekaran","year":"2018","journal-title":"Oncotarget"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Staroseletz, Y., Gaponova, S., Patutina, O., Bichenkova, E., Amirloo, B., Heyman, T., Chiglintseva, D., and Zenkova, M. (2021). Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences. Molecules, 26.","DOI":"10.3390\/molecules26061732"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1021\/acsomega.4c11045","article-title":"Silver Nanoparticles (AgNPs): Comprehensive Insights into Bio\/Synthesis, Key Influencing Factors, Multifaceted Applications, and Toxicity\u2014A 2024 Update","volume":"10","author":"Sati","year":"2025","journal-title":"ACS Omega"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Lebaka, V.R., Ravi, P., Reddy, M.C., Thummala, C., and Mandal, T.K. (2025). Zinc Oxide Nanoparticles in Modern Science and Technology: Multifunctional Roles in Healthcare, Environmental Remediation, and Industry. Nanomaterials, 15.","DOI":"10.3390\/nano15100754"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2023.12.022","article-title":"Types of RNA therapeutics","volume":"Volume 203","year":"2024","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Kang, H., Ga, Y.J., Kim, S.H., Cho, Y.H., Kim, J.W., Kim, C., and Yeh, J.Y. (2023). Small interfering RNA (siRNA)-based therapeutic applications against viruses: Principles, potential, and challenges. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00981-9"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jconrel.2022.10.050","article-title":"Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics","volume":"352","author":"Ramasamy","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.25259\/SNI_14_2021","article-title":"Minimalistic reconstruction of exposed skull in a complex craniovertebral polytrauma","volume":"12","author":"Saha","year":"2021","journal-title":"Surg. Neurol. Int."},{"key":"ref_106","first-page":"4","article-title":"A Novel Strategy for Conservative Management of External Auditory Canal Cholesteatoma: Employing 5-Fluorouracil in Ambulatory Care for Select Patients","volume":"7","author":"Niwa","year":"2023","journal-title":"Arch. Otorhinolaryngol. Neck Surg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"110743","DOI":"10.1016\/j.ijporl.2021.110743","article-title":"In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma","volume":"145","author":"Uzun","year":"2021","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12964-022-00953-w","article-title":"Review of potential medical treatments for middle ear cholesteatoma","volume":"20","author":"Schurmann","year":"2022","journal-title":"Cell Commun. Signal."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9545\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:54:18Z","timestamp":1759247658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":108,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26199545"],"URL":"https:\/\/doi.org\/10.3390\/ijms26199545","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}